|

oral anti-Parkinson's drugs Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

  • Zhujiang Hospital1

Indications

  • Onabotulinumtoxin A1
  • Parkinson's Disease1
  • Overactive Bladder1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.